[ad_1] mirza kadic The DEA has scheduled a hearing in early December to talk about the Justice Department’s proposal to reschedule marijuana to a Class III…
Browsing: Healthcare
[ad_1] HJBC Accenture (NYSE:ACN) has agreed to purchase consus.well being, a German healthcare administration consultancy, expanding its capabilities in the nation. consus.well being provides companies starting…
[ad_1] asbe Pharmaceutical firm Endo (OTCQX:NDOI) mentioned that Blaise Coleman will depart the corporate as President & CEO and from the Board of Directors, efficient on…
[ad_1] Darren415/iStock by way of Getty Images Cannabis-related stocks will come underneath investor scrutiny on Tuesday after the Drug Enforcement Administration (DEA) scheduled a public hearing…
[ad_1] Pfizer (NYSE:PFE) has introduced PfizerForAll, a brand new website that can supply vaccines, medical checks and medicines delivered at residence. PfizerForAll is designed for sufferers…
[ad_1] jetcityimage Eli Lilly (NYSE:LLY) slashed the costs of the 2 lowest doses of its blockbuster weight reduction treatment Zepbound on Tuesday for purchases on its…
[ad_1] Soleno lead asset granted FDA priority review [ad_2] Source: Seekingalpha
[ad_1] Ensysce wins $14M federal grant for lead pain therapy [ad_2] Source: Seekingalpha
[ad_1] Inspire Veterinary Partners to acquire Vetsie.ai [ad_2] Source: Seekingalpha
[ad_1] Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket.…